Oscar Health Quarterly Cash Flow Statement
NYSE: OSCRHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Oscar Health free cash flow
In the quarter ended Jun 30, 2026, Oscar Health generated $2.09 billion of operating cash flow and spent $11.8 million on capital expenditures. That left free cash flow of $2.08 billion, a free-cash-flow margin of 42.6% of revenue. Free cash flow was up 316.3% from the prior year's $499.8 million.
Summary generated from market data by MetaCap's automated system. Methodology
Oscar Health cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 361.83M | 679.02M | -352.43M | -137.48M | -228.49M | 275.51M | -153.28M | -54.39M | 56.31M | 177.48M | -149.84M | -65.70M |
| Net Income growth (YoY) | — | +146.46% | — | — | -505.76% | +55.23% | — | — | — | — | — | — |
| Depreciation & Amortization | 6.03M | 7.02M | 7.88M | 7.31M | 6.97M | 6.73M | 9.23M | 7.50M | 7.60M | 7.81M | 7.74M | 9.19M |
| Stock-Based Compensation | 20.65M | 15.97M | 18.09M | 20.48M | 24.11M | 24.98M | 25.86M | 29.31M | 28.71M | 25.95M | 26.14M | 28.77M |
| Change in Working Capital | 149.25M | -220.95M | 96.53M | 5.33M | 111.64M | -86.80M | 38.27M | 44.70M | 36.06M | 22.19M | 19.64M | -476.00K |
| Operating Cash Flow | 2.09B | 2.62B | 671.90M | -964.66M | 509.07M | 878.54M | 346.82M | -500.14M | 497.15M | 634.36M | 296.87M | -1.15B |
| Capital Expenditures | -11.76M | -8.79M | -9.06M | -9.01M | -9.28M | -9.03M | -6.82M | -7.57M | -7.56M | -5.95M | -6.10M | -6.48M |
| Investing Cash Flow | -2.83B | -590.25M | -48.71M | 150.08M | -168.21M | -174.23M | -31.45M | -577.77M | -477.63M | -300.59M | 172.48M | 225.30M |
| Debt Issued | — | — | 0 | — | — | — | 0 | — | — | — | 0 | 0 |
| Financing Cash Flow | 13.29M | -3.60M | 8.17M | 364.03M | 22.13M | 4.87M | 3.82M | 18.56M | 18.70M | 27.31M | 1.07M | 2.32M |
| Net Change in Cash | -728.97M | 2.03B | 631.37M | -450.54M | 362.99M | 709.19M | 319.19M | -1.06B | 38.23M | 361.08M | 470.41M | -921.64M |
| Free Cash Flow | 2.08B | 2.61B | 662.84M | -973.66M | 499.79M | 869.52M | 340.00M | -507.71M | 489.59M | 628.41M | 290.77M | -1.16B |
This table shows 12 quarterly periods of Oscar Health's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OSCR's reporting calendar. What is a cash flow statement?